Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
desferrioxamine mesilate, Quantity: 500 mg
Hospira Australia Pty Ltd
desferrioxamine mesilate
Injection
Excipient Ingredients:
Intraperitoneal, Intravenous, Intramuscular, Subcutaneous
10 x 10 mL vials
Medicine Listed (Export Only)
(S1) This Schedule is intentionally blank
Desferrioxamine mesilate is a binding agent for iron and aluminium. Desferrioxamine mesilate is used to remove excess iron or aluminium from the body in patients with conditions such as iron poisoning, thalassemia (a heredity type of anemia) haemochromatosis (a disorder of iron metabolism) and aluminium overload due to kidney failure. It may also be used to diagnose iron storage disease and some types of chronic anemias or aluminium overload in some patients.
Visual Identification: A white to cream powder or lyophilised plug; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Listed (Export Only)
2007-04-16